When Phillip Furman received his masters degree in microbiology from the University of South Florida in 1972, he didn't realize he was starting on a path that would lead him to developing antiviral drugs that treat diseases like HIV and hepatitis B and C.
ByMichelle Andrews of Kaiser Health News•Nov 16, 2015
In most states, consumers with HIV or AIDS who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs, according to a new analysis.
Florida insurance regulators will start reviewing health plans for discriminatory practices after three insurers were accused of charging higher prices for HIV drugs.
The Florida Office of Insurance Regulation announced it will review 2016 plans available on HealthCare.gov in Florida for possible discriminatory practices in their coverage of all prescription medications, and will also limit patient cost-sharing of HIV medications to reasonable co-pays.
Insurance companies, perhaps more than previously thought, may be charging the sickest patients extra for drugs under the federal health law, in an effort to discourage them from choosing certain plans, according to a study released Wednesday.
Preferred Medical Plan, the last of four insurers in Florida criticized by AIDS advocacy groups for the high cost of their HIV drugs, voluntarily agreed to cap the prices of the medication last week, according to the Miami Herald and Kaiser Health News. The company agreed to set the out-of-pocket cost limitation to $200 a month for four types of medication. According to the Herald, the Florida Department of Health and Human Services is still investigating federal civil rights co
A federal report found that 24 percent of people with questionable Medicare billing for HIV drugs live in Miami, according to the South Florida Business Journal. That’s remarkable, considering only 2 percent of the nation’s Medicare beneficiaries who get HIV drugs live in the area.